A nurse is caring for a patient with a second-degree Mobitz Type II AV block. The patient's heart rate has dropped to 42 bpm, and he is experiencing dizziness and shortness of breath. Which intervention should the nurse prioritize to address the patient's current condition?

B) Prepare for transcutaneous pacing to stabilize cardiac rhythm.

A) Administer atropine to increase the heart rate.

B) Prepare for transcutaneous pacing to stabilize cardiac rhythm.

C) Increase the patient's fluid intake to support blood pressure.

D) Reposition the patient to a semi-Fowler's position to alleviate shortness of breath.

A patient with a second-degree Mobitz Type II AV block is demonstrating signs of dizziness, shortness of breath, and fatigue, with a heart rate of 42 bpm. What is the most appropriate initial nursing intervention to address the risk of syncope and ensure patient safety while awaiting further medical management?

D) Prepare for transcutaneous pacing as per standing orders

A) Encourage the patient to ambulate with assistance to improve circulation

B) Position the patient in a Trendelenburg position to increase cerebral perfusion

C) Administer supplemental oxygen to address potential hypoxia

D) Prepare for transcutaneous pacing as per standing orders

A patient with a Mobitz Type II AV block is experiencing syncope and has an elevated potassium level of 5.4 mmol/L. The nursing team has administered calcium gluconate and started a low-dose loop diuretic. What is the primary nursing intervention to monitor the effectiveness of these treatments and ensure patient safety?

A) Monitor the patient's heart rate and rhythm continuously

B) Check the patient's blood pressure every 4 hours

C) Assess the patient's respiratory rate and effort hourly

D) Measure the patient's urine output every shift

A patient with a Mobitz Type II AV block is experiencing episodes of syncope and has a potassium level of 5.4 mmol/L. Which of the following interventions should the nurse prioritize to address the patient's current condition?

B) Prepare the patient for transvenous pacing

A) Administer a beta-blocker to manage heart rate

B) Prepare the patient for transvenous pacing

C) Encourage the patient to increase fluid intake to dilute potassium levels

D) Monitor the patient closely for signs of complete heart block

A patient with a transvenous pacemaker presents with persistent fatigue and occasional dizziness despite improved heart rate stabilization. Recent lab results indicate a mild decrease in hemoglobin levels. Which nursing intervention is most appropriate to address the underlying causes of the patient's symptoms?

C) Implement a gradual mobilization plan to improve orthostatic tolerance.

A) Increase the pacing rate to enhance cardiac output and reduce dizziness.

B) Encourage a high-protein diet to address potential nutritional anemia.

C) Implement a gradual mobilization plan to improve orthostatic tolerance.

D) Administer iron supplements to correct the decrease in hemoglobin.

A patient with a history of bradycardia is showing improvement in heart rate after transvenous pacing but continues to experience fatigue and orthostatic hypotension. Recent lab results show a decrease in hemoglobin levels. What should be the nurse's priority intervention to address the patient's symptoms?

C) Educate the patient on slow positional changes to reduce dizziness.

A) Increase fluid intake to address potential dehydration.

B) Recommend dietary modifications to increase iron intake.

C) Educate the patient on slow positional changes to reduce dizziness.

D) Administer supplemental oxygen to improve tissue perfusion.

A patient with iron deficiency anemia and a newly diagnosed episode of atrial fibrillation is initiated on anticoagulation therapy. What priority nursing intervention should the nurse implement to ensure the patient's safety?

C) Assess for signs of bleeding and ensure appropriate anticoagulation dosing.

A) Educate the patient on the importance of dietary iron intake.

B) Monitor the patient's hemoglobin and hematocrit levels regularly.

C) Assess for signs of bleeding and ensure appropriate anticoagulation dosing.

D) Schedule more frequent iron supplementation doses to correct anemia quickly.

A patient with iron deficiency anemia and atrial fibrillation has been started on iron supplementation and anticoagulation therapy. Which nursing intervention is most important to prevent complications related to the new anticoagulation therapy?

B) Monitor for signs of bleeding, such as bruising or blood in the stool.

A) Educate the patient on the importance of a high-fiber diet to prevent constipation.

B) Monitor for signs of bleeding, such as bruising or blood in the stool.

C) Encourage the patient to increase physical activity to improve circulation.

D) Advise the patient to consume vitamin C-rich foods to enhance iron absorption.

A patient with iron deficiency anemia and newly diagnosed atrial fibrillation is prescribed a low-dose beta-blocker. What is the primary nursing intervention to monitor for the effectiveness of this new medication?

A) Check the patient's blood pressure and heart rate regularly

B) Monitor the patient for signs of gastrointestinal bleeding

C) Assess the patient's hemoglobin and hematocrit levels

D) Educate the patient about dietary sources of iron

A patient with iron deficiency anemia and recent atrial fibrillation has been started on a low-dose beta-blocker to manage heart rate and improve hemodynamic stability. Which assessment finding should the nurse prioritize as most concerning after the initiation of the beta-blocker therapy?

B) Heart rate of 55 beats per minute

A) Blood pressure of 100/65 mmHg

B) Heart rate of 55 beats per minute

C) Patient reports feeling less fatigued

D) Serum potassium level of 4.0 mEq/L

atrioventricular heart block - Nursing Case Study

Pathophysiology

• Primary mechanism: Atrioventricular (AV) heart block involves impaired conduction of electrical impulses from the atria to the ventricles, commonly due to fibrosis or sclerosis of the AV node, affecting the normal rhythm and rate of the heart.

• Secondary mechanism: Ischemia or damage to the AV node from coronary artery disease can further disrupt the transmission of impulses, leading to varying degrees of heart block, where the ventricles may not receive adequate signals to contract efficiently.

• Key complication: This impaired conduction can result in bradycardia (slow heart rate) and reduced cardiac output, leading to symptoms such as dizziness, fatigue, and in severe cases, syncope, underscoring the need for timely diagnosis and management to prevent further cardiovascular complications.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Coronary Artery Disease

• Current medications: Metformin, Lisinopril, Aspirin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Episodes of dizziness and fatigue

• Key symptoms: Shortness of breath, palpitations, occasional chest discomfort

• Vital signs: Blood pressure 145/92 mmHg, heart rate 48 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

During the initial assessment, the patient was noted to have a significant bradycardia with a heart rate of 48 bpm, prompting further evaluation to ascertain the degree of atrioventricular block. Over the next 24 hours, the patient's condition began to show signs of deterioration. He experienced increased episodes of dizziness and more pronounced shortness of breath. A repeat vital signs check revealed a further drop in heart rate to 42 bpm, with blood pressure holding at 138/88 mmHg, suggesting a potentially progressing heart block. The patient's skin appeared cool and clammy, and he reported feeling more fatigued than usual, raising concerns about reduced cardiac output and possible hypoperfusion.

Clinicians decided to conduct an electrocardiogram (ECG) to better understand the rhythm disturbance. The ECG revealed a second-degree Mobitz Type II AV block, characterized by intermittent non-conducted P waves, confirming that the electrical impulses from the atria were not consistently reaching the ventricles. This finding was significant, as Mobitz Type II is known for its potential to progress to a complete heart block if left untreated. The team initiated continuous cardiac monitoring and prepared for potential pacemaker insertion, given the risk of further conduction system deterioration. This change in patient status necessitated a reassessment of the overall management plan to stabilize the patient's cardiac rhythm and prevent complications such as syncope or severe bradycardia-induced heart failure.

The patient's condition underscores the importance of vigilant monitoring and timely intervention in managing AV block complications. It also highlights the need for clinical reasoning to adjust treatment plans in response to evolving cardiac findings. Next steps in the patient's care will focus on evaluating the efficacy of the current interventions and determining the need for more advanced therapies, such as transvenous pacing, to maintain adequate cardiac output and prevent further cardiovascular compromise.

Section 2

As the team continued to monitor the patient, a new complication emerged. About 12 hours after initiating continuous cardiac monitoring, the patient began experiencing episodes of syncope. These episodes were brief but concerning, as they indicated that the heart was struggling to maintain adequate perfusion to the brain, likely due to the intermittent nature of the Mobitz Type II AV block. The nursing team noted that each syncopal episode was preceded by a further drop in heart rate, now dipping to as low as 38 bpm during these events. In addition to syncope, the patient complained of increasing fatigue and an inability to perform even minimal physical activity without feeling severely breathless.

Laboratory tests were ordered to rule out electrolyte imbalances and other metabolic causes that might exacerbate the AV block. The results showed a slight elevation in potassium levels at 5.4 mmol/L, which could potentially worsen cardiac conduction issues. The patient’s renal function tests were within normal limits, ruling out acute kidney injury as a cause for the hyperkalemia. In response, the clinical team promptly administered calcium gluconate to stabilize cardiac membranes and started the patient on a low-dose loop diuretic to help manage the hyperkalemia, alongside dietary modifications.

The emergence of syncope and the hyperkalemia required an urgent review of the patient's management plan. The cardiology team was consulted, and it was decided that transvenous pacing would be necessary to ensure stability until a permanent pacemaker could be considered. This decision was based on the need to prevent further syncopal episodes and reduce the risk of sudden cardiac arrest. The patient was prepared for the procedure, and the team discussed with him the potential benefits and risks of pacing, ensuring that he understood and consented to the plan. This proactive approach was essential to mitigate the risk of progression to a complete heart block and to improve the patient's overall prognosis.

Section 3

Following the initiation of transvenous pacing, the patient's condition showed initial signs of stabilization. The heart rate improved, maintaining a more consistent range between 60 and 70 bpm, which helped reduce the frequency of syncopal episodes. However, the nursing team remained vigilant, closely monitoring the patient's vital signs and cardiac rhythm. Despite the improved heart rate, the patient continued to report persistent fatigue and occasional dizziness upon standing, suggesting that while the pacing had addressed the bradycardia, other underlying issues might still be influencing his overall condition.

New diagnostic results revealed that the patient's hemoglobin levels had decreased slightly to 11.2 g/dL from a previous reading of 13.4 g/dL. This mild anemia could potentially contribute to the patient's fatigue and reduced exercise tolerance. Additionally, further electrolyte monitoring showed a gradual normalization of potassium levels to 4.9 mmol/L after the diuretic therapy, alleviating some concerns regarding hyperkalemia's impact on cardiac conduction. The patient's blood pressure remained relatively stable, with readings averaging 110/70 mmHg, although occasional orthostatic hypotension was noted.

In light of these findings, the clinical team decided to conduct further investigations to identify potential causes of the anemia, considering possibilities such as nutritional deficiencies or chronic disease processes. The patient's nutritional intake was assessed, and a comprehensive metabolic panel was ordered to explore other possible etiologies. The team also initiated a plan for gradual mobilization, carefully balancing the need to improve physical activity tolerance with the risk of exacerbating symptoms. These steps were crucial in guiding the next phase of the patient's treatment and ensuring a comprehensive approach to his recovery and long-term management.

Section 4

As the clinical team proceeded with the further investigations, the results of the comprehensive metabolic panel revealed a mild decrease in serum iron levels, with a reading of 45 µg/dL, and a slight reduction in ferritin levels at 12 ng/mL, suggesting iron deficiency as a potential contributor to the patient's anemia. These findings prompted the team to consider nutritional iron deficiency as a contributing factor, possibly exacerbated by the patient's recent dietary habits or gastrointestinal malabsorption. Vitamin B12 and folate levels were also tested and found to be within normal ranges, thereby narrowing the differential diagnosis.

In response to these revelations, the clinical team initiated an iron supplementation regimen to address the iron deficiency. Alongside this, they collaborated with a dietitian to develop a tailored nutritional plan aimed at boosting the patient's iron intake through diet. The plan emphasized iron-rich foods such as lean meats, leafy greens, and fortified cereals. To evaluate the effectiveness of these interventions, the team scheduled follow-up lab tests to monitor hemoglobin and iron levels, aiming to assess improvement over time.

Despite these targeted efforts, the patient experienced a new complication: an episode of atrial fibrillation was detected during routine cardiac monitoring, marked by an irregular heart rhythm and a heart rate fluctuating between 80 and 130 bpm. The occurrence of atrial fibrillation introduced a new layer of complexity to the patient's condition, necessitating the initiation of anticoagulation therapy to reduce the risk of thromboembolic events. This development required careful consideration of the patient's anemia and overall stability, highlighting the need for ongoing vigilance and adaptability in his care plan. The team adjusted the monitoring protocol to increase the frequency of cardiac assessments and ensure timely detection of any further arrhythmias or changes in hemodynamic status.

Section 5

The patient's initial response to the iron supplementation and dietary adjustments appeared promising, with a gradual improvement in energy levels and a slight increase in hemoglobin from 10.2 to 11.0 g/dL over the course of a few weeks. However, during this period, the patient reported experiencing occasional lightheadedness and palpitations, prompting the clinical team to conduct a more comprehensive cardiovascular assessment. Upon examination, the patient's blood pressure was recorded at 95/60 mmHg, and the irregular heart rhythm persisted, with episodes of atrial fibrillation documented alongside paroxysmal ventricular ectopy. These findings raised concerns about the stability of the patient's cardiovascular status, particularly in the context of ongoing anemia and new anticoagulation therapy, necessitating a re-evaluation of the treatment strategy.

New diagnostic results from a repeat echocardiogram showed mild left atrial enlargement and preserved ejection fraction, but with evidence of increased left ventricular filling pressures. The patient's serum electrolytes were within normal limits, yet the B-type natriuretic peptide (BNP) level was elevated at 380 pg/mL, suggesting some degree of cardiac strain or heart failure. In light of these developments, the clinical team considered the potential impact of the iron deficiency anemia on myocardial oxygen delivery and the possibility that the recent atrial fibrillation episode might have been exacerbated by underlying changes in cardiac structure or function. This prompted the addition of a low-dose beta-blocker to the patient's regimen to help manage the heart rate and improve hemodynamic stability.

The introduction of the beta-blocker, alongside ongoing monitoring and adjustments to the patient's care plan, aimed to provide a more comprehensive approach to the multifaceted nature of the patient's condition. As the team continued to balance the management of arrhythmias with the correction of anemia, they emphasized the importance of regular follow-up appointments and patient education on recognizing symptoms that might indicate further complications. This proactive approach was designed to optimize the patient's cardiac health while addressing nutritional deficiencies, ultimately guiding the next steps in the patient's journey toward recovery.